サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1421595

創薬サービス市場、シェア、規模、動向、産業分析レポート：タイプ別、最終用途別、地域別、セグメント別予測、2024年～2032年

Drug Discovery Services Market Share, Size, Trends, Industry Analysis Report, By Type (Small molecules, Large Molecules) By End-Use; By Region; Segment Forecast, 2024 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 117 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
創薬サービス市場、シェア、規模、動向、産業分析レポート：タイプ別、最終用途別、地域別、セグメント別予測、2024年～2032年
出版日: 2023年11月23日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの最新調査によると、世界の創薬サービス市場規模は2032年までに640億8,000万米ドルに達する見込みです。創薬サービス市場シェア、規模、動向、産業分析レポート、タイプ別（低分子、高分子）、最終用途別、地域別、セグメント別予測レポート、2024～2032年」は、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供します。

疾患の治療や制御に適した物質を探索するプロセスは、創薬として知られています。通常、潜在的な薬剤の探索は、魅力的な生物学的特性を示す分子や、疾患の進展に関与することが知られている生物学的標的と相互作用する分子から始まる。

近年の技術の進歩は、創薬の情勢を一変させ、より洗練された、より精密な、より多くの時間を投資する領域へと創薬を昇華させました。かつては、医薬品開発は主に伝統的な治療薬に含まれる有効成分をピンポイントで特定することに頼っており、その代表例がペニシリンの発見でした。

製薬業界は、革新的で効果的な治療薬のあくなき追求により、研究開発（R&D）予算の大幅な増加を促しています。世界の疾病負担が増加の一途をたどる中、アンメット・メディカル・ニーズに対応できる新薬を求める声が高まっています。その結果、製薬会社は画期的な治療法を求めて研究開発投資を強化する意欲を高めています。このようなコミットメントの高まりが、創薬サービスに対する需要の高まりを後押ししています。

科学的知識と技術の進歩により、創薬研究の状況は大きく変化しています。ゲノミクス、プロテオミクス、ハイスループットスクリーニング、計算モデリング、その他の最先端ツールの出現は、新薬候補の同定と開発のプロセスを複雑に変化させました。こうした画期的な進歩は、専門的な機器、専門知識、インフラへの多額の投資を必要とし、結果として研究開発費の高騰につながっています。

創薬サービス市場は、COVID-19の大流行によって大きな変貌を遂げ、業界の多方面に影響を与えました。この世界の健康危機は、感染症へのスポットライトを強めました。COVID-19治療薬とワクチンに対する差し迫った需要は、感染症研究開発の領域における多額の投資と共同研究に拍車をかけた。創薬サービスを提供する数多くの企業が、このウイルスに対抗するために特別に設計された薬剤や治療法の開発に重点を置くようになった。この変化により、対象の特定、リード化合物の最適化、感染症に対する前臨床試験の実施に関するサービスへのニーズが高まった。

さらに、2021年6月にNational Library of Medicineに掲載された研究では、冠動脈疾患（CAD）が世界の健康に与える影響の大きさが強調されました。CADだけで年間約61万人が死亡しており、推定死亡者数の4人に1人を占め、米国における死亡原因の第1位となっています。CADの発症率が上昇するにつれ、この差し迫った医療ニーズに対処するための効果的な冠動脈ステント装置に対する需要が高まっています。その結果、この要因が予測期間を通じて冠動脈ステントの需要を促進すると予測されています。

創薬サービス市場レポートハイライト

  • 2022年、低分子セグメントは創薬サービス市場において最大の売上シェアを占めました。低分子はそのサイズが小さいため、細胞膜を容易に通過し、細胞内経路を正確に対象にできることが高く評価されています。創薬における低分子の利用は、その数多くの利点により、ますます一般的になってきています。長年にわたり、製薬業界は低分子をベースにした医薬品の創製に成功し、幅広い病状の治療に有効であることを証明してきました。
  • 予測期間中、医薬品分野が最大の市場シェアを占めています。企業は、画期的な治療につながる新薬候補を発見したいという願望を原動力に、研究開発に多大なリソースを割いています。製薬企業やバイオテクノロジー企業は医薬品開発に秀でており、委託研究機関やサービスプロバイダーとの戦略的パートナーシップを維持しています。こうした提携により、創薬サービスプロバイダーの専門的なスキルやリソースを活用することが可能となり、より効果的かつ効率的な創薬プロセスが実現します。
  • 2022年には北米が最大市場を占め、北米の製薬・バイオテクノロジー部門は活況を呈しており、創薬サービスの需要を牽引する極めて重要な役割を果たしています。同大陸はまた、有名な研究センター、権威ある学術機関、強力な政府支援からなる強固で永続的な研究エコシステムの本拠地でもあり、これらすべてが科学的努力の推進に貢献しています。同地域の市場リーダーシップは、高度に熟練した研究者や科学者の豊富さ、最先端の技術力によってさらに強化されています。
  • アジア太平洋は、製薬セクターの拡大により、創薬サービス市場において最も速い成長を占めているが、その成功はさまざまな要因によるものです。第一に、同地域では慢性的な生活習慣病の罹患率が上昇しているため、企業はこれらの疾患に対する治療法の開発に投資しています。第二に、この地域におけるバイオ医薬品企業の増加が創薬サービスの機会を増やし、市場の成長を後押ししています。
  • 最後に、効果的な事業戦略の採用や地域的な協力関係は、市場に大きなプラスの影響を及ぼすと予想されます。さらに、研究開発の促進を目的とした政府の取り組みが、有利な規制の枠組みや税制優遇措置と相まって、この地域の市場成長をさらに後押ししています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の創薬サービス市場別洞察

  • 創薬サービス市場-業界スナップショット
  • 創薬サービス市場力学
    • 促進要因と機会
      • 数多くの治療プロセスに対する新たな治療法に対する需要の増加
      • 製薬とバイオテクノロジー分野の研究開発支出の増加
    • 抑制要因と課題
      • 創薬と動物の使用を管理する厳格な規制
  • PESTLE分析
  • 創薬サービス業界の動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の創薬サービス市場、タイプ別

  • 主要調査結果
  • イントロダクション
  • 低分子
  • 高分子

第6章 世界の創薬サービス市場、最終用途別

  • 主要調査結果
  • イントロダクション
  • 医薬品
  • バイオテクノロジー
  • 学術
  • その他

第7章 世界の創薬サービス市場、地域別

  • 主要調査結果
  • イントロダクション
    • 創薬サービス市場評価、地域別、2019～2032年
  • 創薬サービス市場-北米
    • 北米：創薬サービス市場、最終用途別、2019～2032年
    • 北米：創薬サービス市場、タイプ別、2019～2032年
    • 創薬サービス市場-米国
    • 創薬サービス市場-カナダ
  • 創薬サービス市場-欧州
    • 欧州：創薬サービス市場、最終用途別、2019～2032年
    • 欧州：創薬サービス市場、タイプ別、2019～2032年
    • 創薬サービス市場-英国
    • 創薬サービス市場-フランス
    • 創薬サービス市場-ドイツ
    • 創薬サービス市場-イタリア
    • 創薬サービス市場-スペイン
    • 創薬サービス市場-オランダ
    • 創薬サービス市場-ロシア
  • 創薬サービス市場-アジア太平洋
    • アジア太平洋：創薬サービス市場、最終用途別、2019～2032年
    • アジア太平洋：創薬サービス市場、タイプ別、2019～2032年
    • 創薬サービス市場-中国
    • 創薬サービス市場-インド
    • 創薬サービス市場-マレーシア
    • 創薬サービス市場-日本
    • 創薬サービス市場-インドネシア
    • 創薬サービス市場-韓国
  • 創薬サービス市場-中東・アフリカ
    • 中東・アフリカ：創薬サービス市場、最終用途別、2019～2032年
    • 中東・アフリカ：創薬サービス市場、タイプ別、2019～2032年
    • 創薬サービス市場-サウジアラビア
    • 創薬サービス市場-アラブ首長国連邦
    • 創薬サービス市場-イスラエル
    • 創薬サービス市場-南アフリカ
  • 創薬サービス市場-ラテンアメリカ
    • ラテンアメリカ：創薬サービス市場、最終用途別、2019～2032年
    • ラテンアメリカ：創薬サービス市場、タイプ別、2019～2032年
    • 創薬サービス市場-メキシコ
    • 創薬サービス市場-ブラジル
    • 創薬サービス市場-アルゼンチン

第8章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • Aurigene Discovery Technologies
  • Charles River Laboratories International Inc.
  • Eurofins Scientific
  • Evotec
  • Frontage Labs
  • Galapagos NV
  • General Electric
  • Genscript
  • Laboratory Corporations of America Holdings
  • PPD Inc.
  • Syngene International Limited
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec
図表

List of Tables

  • Table 1 Global Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 2 Global Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 3 Drug Discovery Services Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 5 North America: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 6 U.S.: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 7 U.S.: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 8 Canada: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 9 Canada: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 10 Europe: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 11 Europe: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 12 UK: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 13 UK: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 14 France: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 15 France: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 16 Germany: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 17 Germany: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 18 Italy: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 19 Italy: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 20 Spain: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 21 Spain: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Russia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 25 Russia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 28 China: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 29 China: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 30 India: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 31 India: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 34 Japan: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 35 Japan: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 38 South Korea: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 39 South Korea: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 44 UAE: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 45 UAE: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 46 Israel: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 47 Israel: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 48 South Africa: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 49 South Africa: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 50 Latin America: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 51 Latin America: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Mexico: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 53 Mexico: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Brazil: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 55 Brazil: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 56 Argentina: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 57 Argentina: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Drug Discovery Services Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by End-Use
  • Figure 7 Global Drug Discovery Services Market, by End-Use, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Type
  • Figure 9 Global Drug Discovery Services Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10 Drug Discovery Services Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Drug Discovery Services Market
目次
Product Code: PM3920

The global drug discovery services market size is expected to reach USD 64.08 Billion by 2032, according to a new study by Polaris Market Research. The "Drug Discovery Services Market Share, Size, Trends, Industry Analysis Report, By Type (Small molecules, Large Molecules) By End-Use; By Region; Segment Forecast report, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The process of searching for a substance suitable for treating and controlling diseases is known as drug discovery. Typically, the quest for a potential drug starts with a molecule displaying fascinating biological characteristics or interacting with a biological target known to play a role in the advancement of a disease.

Recent technological progress has transformed the landscape of drug discovery, elevating it to a realm of greater sophistication, precision, and increased time investment. In the past, drug development primarily relied on pinpointing the active constituents within traditional remedies, a prime example being the discovery of penicillin.

The pharmaceutical industry's relentless pursuit of innovative and effective therapeutics is prompting a significant increase in research and development (R&D) budgets. As the global disease burden continues to escalate, there is a growing call for new medications capable of addressing unmet medical needs. Consequently, pharmaceutical companies are increasingly motivated to augment their R&D investments in the quest for groundbreaking treatments. This heightened commitment, in turn, fuels a rising demand for drug discovery services.

The landscape of drug discovery research has evolved significantly due to advancements in scientific knowledge and technology. The emergence of genomics, proteomics, high-throughput screening, computational modeling, and other state-of-the-art tools has intricately transformed the process of identifying and developing new drug candidates. These breakthroughs necessitate substantial investments in specialized equipment, expertise, and infrastructure, consequently leading to an escalation in R&D expenditures.

The drug discovery services market underwent a profound transformation due to the COVID-19 pandemic, impacting multiple facets of the industry. This global health crisis intensified the spotlight on infectious diseases. The pressing demand for COVID-19 treatments and vaccines spurred substantial investments and collaborations within the realm of infectious disease research and development. Numerous providers of drug discovery services pivoted their focus toward the development of drugs and treatments designed specifically to combat the virus. This change led to a growing need for services related to identifying targets, optimizing leads, and conducting preclinical testing for infectious diseases.

Additionally, a study published in the National Library of Medicine in June 2021 highlighted the significant impact of coronary artery disease (CAD) on global health. CAD alone is responsible for approximately 610,000 deaths annually, accounting for an estimated one in four deaths and making it the foremost cause of mortality in the United States. With the incidence of CAD rising, there is a growing demand for effective coronary stent devices to address this pressing medical need. Consequently, this factor is projected to drive the demand for coronary stents throughout the forecast period.

Drug Discovery Services Market Report Highlights

  • In 2022, the small molecule segment held the largest revenue share in the drug discovery services market, small molecules are highly valued for their small size, which enables them to easily pass through cell membranes and precisely target intracellular pathways. The use of small molecules in drug discovery has become increasingly popular due to their numerous advantages. For many years, the pharmaceutical industry has successfully created drugs based on small molecules, proving their effectiveness in treating a wide range of medical conditions.
  • The pharmaceutical segment accounted for the largest market share during the forecast period. Companies allocate significant resources to research and development, driven by the desire to discover new drug candidates that can lead to groundbreaking treatments. Pharmaceutical and biotechnology firms excel in drug development and maintain strategic partnerships with contract research organizations and service providers. These collaborations enable them to leverage the specialized skills and resources of drug discovery service providers, resulting in more effective and efficient drug discovery processes.
  • In 2022, North America dominated the largest market, North America's pharmaceutical and biotechnology sectors are thriving, playing a pivotal role in driving the demand for drug discovery services. The continent is also home to a robust and enduring research ecosystem comprising renowned research centers, prestigious academic institutions, and strong government support, all contributing to advancing scientific endeavors. The region's market leadership is further bolstered by its abundance of highly skilled researchers, scientists, and state-of-the-art technological capabilities.
  • The Asia-Pacific region accounted for the fastest growth in the Drugs Discovery Services Market due to the expansion of the pharmaceutical sector owes its success to a variety of factors. Firstly, the rising incidence of chronic lifestyle-related illnesses within the region has driven companies to invest in developing treatments for these conditions. Secondly, the increasing number of biopharmaceutical enterprises in the area has created more opportunities for drug discovery services, thus fueling market growth.
  • Lastly, the adoption of effective business strategies and regional collaborations is expected to exert a significant positive influence on the market. Moreover, government initiatives aimed at promoting research and development, coupled with favorable regulatory frameworks and tax incentives, have further bolstered market growth in this region.
  • The global key market players include: Aurigene Discovery Technologies, Charles River Laboratories International Inc., Eurofins Scientific, Evotec, Frontage Labs, Galapagos NV, General Electric, Genscript, Laboratory Corporations of America Holdings, PPD Inc., Syngene International Limited, Thermo Fisher Scientific Inc., and WuXi AppTec.

Polaris Market Research has segmented the drug discovery services market report based on type, end-use, and region:

Drug Discovery Services, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Small Molecules
  • Large Molecules

Drug Discovery Services, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pharmaceutical
  • Biotechnology
  • Academics
  • Others

Drug Discovery Services, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Drug Discovery Services Market Insights

  • 4.1. Drug Discovery Services Market - Industry Snapshot
  • 4.2. Drug Discovery Services Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing demand for novel therapies for numerous therapeutic processes
      • 4.2.1.2. Rising expenditure in R&D in pharmaceutical and biotechnology sector
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Rigorous regulations governing the drug discovery and animal usage
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Drug Discovery Services Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Drug Discovery Services Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Drug Discovery Services, by Type, 2019-2032 (USD Billion)
  • 5.3. Small Molecules
    • 5.3.1. Global Drug Discovery Services Market, by Small Molecules, by Region, 2019-2032 (USD Billion)
  • 5.4. Large Molecules
    • 5.4.1. Global Drug Discovery Services Market, by Large Molecules, by Region, 2019-2032 (USD Billion)

6. Global Drug Discovery Services Market, by End-Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • 6.3. Pharmaceutical
    • 6.3.1. Global Drug Discovery Services Market, by Pharmaceutical, by Region, 2019-2032 (USD Billion)
  • 6.4. Biotechnology
    • 6.4.1. Global Drug Discovery Services Market, by Biotechnology, by Region, 2019-2032 (USD Billion)
  • 6.5. Academics
    • 6.5.1. Global Drug Discovery Services Market, by Academics, by Region, 2019-2032 (USD Billion)
  • 6.6. Others
    • 6.6.1. Global Drug Discovery Services Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Drug Discovery Services Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Drug Discovery Services Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Drug Discovery Services Market - North America
    • 7.3.1. North America: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
    • 7.3.2. North America: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.3.3. Drug Discovery Services Market - U.S.
      • 7.3.3.1. U.S.: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.3.4. Drug Discovery Services Market - Canada
      • 7.3.4.1. Canada: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • 7.4. Drug Discovery Services Market - Europe
    • 7.4.1. Europe: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.4.3. Drug Discovery Services Market - UK
      • 7.4.3.1. UK: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.4.4. Drug Discovery Services Market - France
      • 7.4.4.1. France: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.4.5. Drug Discovery Services Market - Germany
      • 7.4.5.1. Germany: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.4.6. Drug Discovery Services Market - Italy
      • 7.4.6.1. Italy: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.4.7. Drug Discovery Services Market - Spain
      • 7.4.7.1. Spain: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.4.8. Drug Discovery Services Market - Netherlands
      • 7.4.8.1. Netherlands: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.4.9. Drug Discovery Services Market - Russia
      • 7.4.9.1. Russia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • 7.5. Drug Discovery Services Market - Asia Pacific
    • 7.5.1. Asia Pacific: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.5.3. Drug Discovery Services Market - China
      • 7.5.3.1. China: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.5.4. Drug Discovery Services Market - India
      • 7.5.4.1. India: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.5.5. Drug Discovery Services Market - Malaysia
      • 7.5.5.1. Malaysia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.5.6. Drug Discovery Services Market - Japan
      • 7.5.6.1. Japan: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.5.7. Drug Discovery Services Market - Indonesia
      • 7.5.7.1. Indonesia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.5.8. Drug Discovery Services Market - South Korea
      • 7.5.8.1. South Korea: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • 7.6. Drug Discovery Services Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.6.3. Drug Discovery Services Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.6.4. Drug Discovery Services Market - UAE
      • 7.6.4.1. UAE: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.6.5. Drug Discovery Services Market - Israel
      • 7.6.5.1. Israel: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.6.6. Drug Discovery Services Market - South Africa
      • 7.6.6.1. South Africa: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • 7.7. Drug Discovery Services Market - Latin America
    • 7.7.1. Latin America: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.7.3. Drug Discovery Services Market - Mexico
      • 7.7.3.1. Mexico: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.7.4. Drug Discovery Services Market - Brazil
      • 7.7.4.1. Brazil: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.7.5. Drug Discovery Services Market - Argentina
      • 7.7.5.1. Argentina: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Aurigene Discovery Technologies
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Charles River Laboratories International Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Eurofins Scientific
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Evotec
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Frontage Labs
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Galapagos NV
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. General Electric
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Genscript
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Laboratory Corporations of America Holdings
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. PPD Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Syngene International Limited
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Thermo Fisher Scientific Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. WuXi AppTec
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development